Cargando…
LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
Cisplatin resistance is a major therapeutic challenge in non-small cell lung cancer (NSCLC). Herein, the regulatory role of long non-coding RNA (lncRNA) ITGB2-AS1 in regulating NSCLC cisplatin resistance was investigated. NSCLC cisplatin resistance cells were constructed using A549 and H1975 cells....
Autores principales: | Chen, Huiyong, Wang, Linhui, Liu, Jingting, Wan, Zihao, Zhou, Lin, Liao, Hongliang, Wan, Renping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308868/ https://www.ncbi.nlm.nih.gov/pubmed/37370246 http://dx.doi.org/10.1080/15384047.2023.2223377 |
Ejemplares similares
-
LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2
por: Liu, Mengyao, et al.
Publicado: (2018) -
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
por: Li, Zewu, et al.
Publicado: (2019) -
LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular Carcinoma
por: Hu, Yuting, et al.
Publicado: (2021) -
Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma
por: Li, Wen, et al.
Publicado: (2021) -
A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
por: Liao, Shenling, et al.
Publicado: (2021)